A large Australian study showed atypical depression has distinct genetic, clinical, and treatment-response features. Read ...

The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...

Monoamine oxidase inhibitors were linked to the highest risk for cardiovascular Standardized MedDRA Queries. Dopamine reuptake inhibition and binding inhibition are linked to antidepressant-related ...

Depression is a debilitating disorder. Globally, around 350 million patients worldwide live with depression, and this could increase to 400 million by 2029. The ...

Taking certain antidepressants at the time of a traumatic brain injury (TBI) is not associated with an increased risk of ...

EEG-based machine learning predicted SSRI treatment response in depression with high accuracy. Learn how brain signals could ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Evecxia Therapeutics—the first company dedicated to realizing the therapeutic potential of Serotonin Synthesis Amplification to treat central nervous ...

Shandong Quanzhong Biomedical Technology Co. Ltd. has synthesized monoamine transmitter reuptake inhibitors reported to be useful for the treatment of neurological disorders, depression, autism, pain, ...

SSRIs enhance CD8 T cell antitumor activity by inhibiting SERT, an immune checkpoint in tumors, suggesting potential repurposing for cancer immunotherapy. High intratumoral SERT levels correlate with ...

Science News: Awais Aftab, clinical assistant professor of psychiatry at the School of Medicine, explained how selective serotonin reuptake inhibitors or SSRIs are not considered addictive. “They ...